The Right Choice: Direct Compression Lactose in Drug Development & Sustainability

Direct Compression Lactose in Drug Development & Sustainability

Balancing Performance, Process Efficiency, and Environmental Responsibility

In oral solid dosage form development, excipient selection can significantly influence both manufacturing efficiency and the final product’s quality. Direct Compression (DC) lactose has become a cornerstone excipient in tablet manufacturing, offering an efficient, cost-effective alternative to traditional wet granulation. Its ability to deliver excellent flowability and compressibility makes it a go-to choice for formulators aiming to streamline processes while maintaining robust tablet performance.

Why Direct Compression Lactose Matters in Modern Drug Development

The pharmaceutical industry faces increasing pressure to shorten development timelines, improve product quality, and reduce manufacturing costs. DC lactose supports these objectives by:

• Enabling simpler manufacturing – Eliminates wet granulation steps, reducing processing time and equipment needs.
• Enhancing formulation robustness – Offers consistent particle size distribution and mechanical properties for better tablet uniformity.

These benefits translate into faster scale-up, reduced production costs, and improved batch-to-batch reproducibility—key drivers for both generics and innovative drug developers.

The Sustainability Imperative

Sustainability is no longer a “nice to have” in pharma—it’s a requirement. Regulatory agencies, healthcare providers, and patients increasingly expect medicines to be developed and produced with reduced environmental impact. DC lactose contributes to greener manufacturing by:

• Lowering energy consumption – Fewer processing steps mean less energy usage compared to granulation.
• Reducing water usage – No wet granulation stage, which often requires significant amounts of purified water.
• Minimizing waste – Streamlined processes and improved yield reduce material loss.

In an industry where sustainability metrics are under greater scrutiny, switching to direct compression processes can help companies meet environmental targets without compromising product performance.

5 Sustainability Gains from Switching to DC Lactose

1. Less Energy Use – No drying step required, cutting energy consumption.
2. Lower Water Footprint – Eliminates the need for purified water in wet granulation.
3. Reduced CO₂ Emissions – Streamlined processing means fewer equipment runs and shorter cycles.
4. Less Material Waste – Higher yield and reduced product loss during manufacturing.
5. Smaller Facility Impact – Fewer process steps mean less equipment space and infrastructure demands.

Direct Compression Lactose: Streamlined, efficient, and better for the planet.

WEBINAR REGISTRATION

What Armor Pharma Brings to the Table

Armor Pharma offers a dedicated range of pharmaceutical-grade lactose excipients designed specifically for direct compression applications. By combining expertise in dairy processing with deep knowledge of pharmaceutical manufacturing needs, Armor Pharma provides:

• Tailored particle engineering for optimal flow and compressibility.
• Consistent quality and regulatory compliance meeting global pharmacopeia standards.
• Sustainable sourcing and manufacturing aligned with corporate responsibility goals.
• Technical support to help formulators

Whether for high-speed tableting, moisture-sensitive actives, or patient-centric dosage forms, Armor Pharma’s DC lactose portfolio offers reliable, sustainable solutions that bridge the gap between performance and environmental responsibility.

In the upcoming webinar, you’ll learn how DC lactose can boost efficiency, improve drug performance, and support responsible, science-driven choices.

Webinar Key Topics:

• DC lactose for enhancing drug formulations
• Lactose as a smart excipient choice for science & responsibility
• Armor Pharma & their Direct Compression grades

Discover how Armor Pharma’s Direct Compression lactose grades can transform your formulations.

Date & Time & Timezone: Sep 16, 2025, 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

For more information & registration here:

WEBINAR REGISTRATION

Speaker:

Mathilde Fontaine

Marketing Manager Pharma, Armor Pharma

Mathilde Fontaine holds a Bachelor’s degree in Biochemistry and a Master’s degree in Marketing and Biology, providing her with a blend of scientific and marketing expertise.

With 8 years of experience, she is currently the Marketing Manager & Sales pharma at Armor Pharma, part of the Savencia group, where she effectively integrates strategic marketing with commercial operations. Her career spans the agro-food and dietary supplements sectors, where she has honed her skills in product management, market analysis, and brand development.

Marie Charbaut

Technical Support & Development Project Leader, Armor Pharma

Marie Charbaut holds an Engineering chemistry ‘s degree, a Master of Science degree in Chemistry with Biological Chemistry and a specialization pharmaceutical diploma in Drug Development and Analysis.

She started her career as a bioanalyst in Drug metabolism and Pharmacokinetic. Then she worked as an analytical scientist on Leachables and Extractables and as a powder formulation scientist on Dry Powder Inhalers.

Currently she is working at Armor Pharma where her main fields of expertise are the applications of lactose for Oral Solid Dosage Forms leading the galenic laboratory, inhalation lactose and customer technical support.

 

Liliane Kerriou

R&D Division Manager, Armor Pharma

Liliane Kerriou holds a Master’s degree in Biochemistry and Molecular Biology, complemented by her education in Agro-industry and Agricultural Affairs.

With over 18 years of experience, she is the R&D Division Manager Pharma at Armor*, part of the Savencia group, where she has been leading research and development initiatives for over 9 years.

Additionally, she serves as the Corporate Social Responsibility Project Leader at Armor*, accordingly to her strong investment on sustainable initiatives such as “Time for the Planet”. Her career includes significant roles in the dairy and food technology sectors, where her leadership and communication skills have driven innovation

 

Source: Armor Pharma, Pharma Excipients, The Right Choice: Direct Compression Lactose in Drug Development & Sustainability